Sotera Health (NASDAQ:SHC) Receives $16.92 Average Target Price from Analysts

Shares of Sotera Health (NASDAQ:SHC) have received an average recommendation of “Moderate Buy” from the six research firms that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $16.92.

A number of analysts have recently issued reports on SHC shares. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $20.00 price objective on shares of Sotera Health in a research report on Monday, March 4th. Barclays decreased their price target on shares of Sotera Health from $19.00 to $14.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 10th. TheStreet raised Sotera Health from a “d” rating to a “c-” rating in a report on Tuesday, February 27th. Piper Sandler initiated coverage on shares of Sotera Health in a research report on Tuesday, May 21st. They issued a “neutral” rating and a $13.00 target price for the company. Finally, KeyCorp started coverage on shares of Sotera Health in a research note on Tuesday, February 6th. They issued a “sector weight” rating on the stock.

Insider Buying and Selling at Sotera Health

In other news, insider Michael P. Rutz sold 83,109 shares of Sotera Health stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.31, for a total transaction of $1,189,289.79. Following the sale, the insider now directly owns 544,409 shares of the company’s stock, valued at $7,790,492.79. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Sotera Health news, Director Pincus & Co. Warburg sold 16,594,363 shares of Sotera Health stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.31, for a total value of $237,465,334.53. Following the completion of the sale, the director now directly owns 88,822,952 shares in the company, valued at $1,271,056,443.12. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Michael P. Rutz sold 83,109 shares of Sotera Health stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.31, for a total transaction of $1,189,289.79. Following the completion of the sale, the insider now directly owns 544,409 shares of the company’s stock, valued at $7,790,492.79. The disclosure for this sale can be found here. Company insiders own 55.12% of the company’s stock.

Hedge Funds Weigh In On Sotera Health

A number of institutional investors have recently modified their holdings of SHC. Janus Henderson Group PLC increased its stake in Sotera Health by 43.6% in the 1st quarter. Janus Henderson Group PLC now owns 14,892,868 shares of the company’s stock valued at $178,865,000 after buying an additional 4,525,056 shares during the last quarter. Vanguard Group Inc. lifted its stake in Sotera Health by 27.0% in the first quarter. Vanguard Group Inc. now owns 12,145,110 shares of the company’s stock valued at $145,863,000 after purchasing an additional 2,579,248 shares during the last quarter. Hawk Ridge Capital Management LP increased its position in Sotera Health by 26.9% in the third quarter. Hawk Ridge Capital Management LP now owns 2,830,614 shares of the company’s stock worth $42,403,000 after buying an additional 600,600 shares during the last quarter. P2 Capital Partners LLC raised its stake in shares of Sotera Health by 27.0% in the fourth quarter. P2 Capital Partners LLC now owns 2,350,000 shares of the company’s stock valued at $39,598,000 after buying an additional 500,000 shares during the period. Finally, Irenic Capital Management LP raised its stake in Sotera Health by 103.2% in the 4th quarter. Irenic Capital Management LP now owns 2,233,195 shares of the company’s stock valued at $37,629,000 after acquiring an additional 1,134,039 shares during the period. 91.03% of the stock is owned by institutional investors and hedge funds.

Sotera Health Trading Up 0.1 %

Sotera Health stock opened at $11.20 on Thursday. The company has a debt-to-equity ratio of 5.39, a current ratio of 3.20 and a quick ratio of 2.86. The firm has a 50-day moving average of $11.43 and a 200-day moving average of $13.82. The company has a market cap of $3.17 billion, a price-to-earnings ratio of 58.95 and a beta of 2.08. Sotera Health has a one year low of $10.71 and a one year high of $19.40.

Sotera Health (NASDAQ:SHC) last released its earnings results on Thursday, May 2nd. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.01). Sotera Health had a net margin of 5.09% and a return on equity of 48.47%. The firm had revenue of $248.18 million during the quarter, compared to the consensus estimate of $254.73 million. On average, equities analysts expect that Sotera Health will post 0.63 earnings per share for the current fiscal year.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.